Antianginal Therapy Before Percutaneous Coronary Intervention
Author(s) -
William B. Borden,
John A. Spertus,
Alvin I. Mushlin,
Matthew T. Roe,
Lisa A. McCoy,
Rita F. Redberg
Publication year - 2013
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.112.000215
Subject(s) - percutaneous coronary intervention , medicine , cardiology , myocardial infarction
The regional variability of percutaneous coronary intervention (PCI) rates may be explained by variations in the medical treatment of stable coronary artery disease. We sought to determine whether greater regional use of antianginal medications in PCI patients is associated with lower regional rates of PCI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom